Two Senior Executives and Nine Members Appointed to the Canada Foundation for Innovation

September 17, 1997

Ottawa, September 17, 1997-Dr. John Evans, Chair of the Canada Foundation for Innovation, today announced the appointments of Dr. Keith Brimacombe as President and CEO, and of Dr. Denis Gagnon as Senior Vice President of the corporation. He also announced that nine prominent Canadians have been appointed members of the Foundation. 

"Dr. Brimacombe and Dr. Gagnon possess the right mix of academic and private-sector experience to ensure the Foundation keeps a strong focus on the partnership approach that is at the core of its mandate," said Dr. Evans. "Both are highly respected by their peers and will play a critical role in the successful launch of this exciting new organization". 

Dr. Brimacombe and Dr. Gagnon will be responsible for developing and implementing policies and programs designed to modernize Canada's research infrastructure. They will also build partnerships with the private, voluntary and public sectors to invest in research infrastructure projects in Canadian institutions. Their appointments are effective October 1, 1997.
 
Appointed Members of the Foundation are Dr. Jim Friesen, Dr. Art Hanson, Dr. Monique Lefebvre, Dr. Julia Levy, Mrs. Judith Maxwell, Mrs. Edythe A. Parkinson-Marcoux, Mr. Guy Saint-Pierre, Dr. Matt Spence and Dr. Ron Steer. The new members join six others who were appointed by the government on July 31, 1997: Dr. Martha Piper, Dr. Peter J. Nicholson, Dr. Angus Bruneau, Dr. Gilles Cloutier, Ms. Dorothy Lamont and Mr. Robert J. Giroux. 

"These individuals bring a wealth of experience in key areas of research and partnerships with universities, hospitals, industry and the voluntary sector," said Dr. Evans. "They will play an essential role in helping the Foundation achieve its mandate to enhance the capability of Canadian institutions to carry out leading edge research and develop technology that benefits all Canadians." 

The Foundation's 15 Members, whose roles are similar to the shareholders of a corporation, are responsible for approving the organization's financial controls, audited statements, and annual report. Their first task will be to elect eight of the Foundation's 15 directors. Dr. John Evans also serves as a director. Six other directors will be appointed by the government of Canada at a later date. Drawn primarily from the research and business communities, the directors will decide which projects should receive support and how the Foundation's funds will be allocated. 

The Canada Foundation for Innovation is an independent, not-for-profit corporation established in May 1997 with funds from the federal government. Its mandate is to invest in infrastructure for research and development in Canadian universities, colleges, hospitals and other not-for-profit research institutions. The Foundation's initial capital of $800 million is to be committed over the next five years on research infrastructure projects. The Foundation's investments will be made in partnership with the private and the voluntary sectors as well as governments. 
 

Chair: Dr. John Evans
Executive Appointments
Dr. J. Keith Brimacombe President & Chief Executive Officer, Canada Foundation for Innovation
Dr. Denis Gagnon Senior Vice President, Canada Foundation for Innovation
Members
Dr. Jim Friesen Chair, Banting and Best Department of Medical Research, University of Toronto
Dr. Art Hanson President, International Institute for Sustainable Development
Dr. Monique Lefebvre President, Quebecor Multimedia
Dr. Julia Levy President & Chief Executive Officer, Scientific Officer, QLT PhotoTherapeutics Inc.
Mrs. Judith Maxwell
Mrs. Edythe A. Parkinson-Marcoux Former President, CS Resources Limited
Mr. Guy Saint-Pierre Chairman of the Board, SNC-Lavalin Group Incorporated
Dr. Matt Spence President, Alberta Heritage Foundation for Medical Research
Dr. Ron Steer Professor, Department of Chemistry, University of Saskatchewan



TWO EXECUTIVES AND NINE MEMBERS APPOINTED TO THE CANADA FOUNDATION FOR INNOVATION

Biographies 

Dr. J. Keith Brimacombe 
Dr. Brimacombe is Director of The Centre for Metallurgical Process Engineering and holder of the Alcan Chair in Materials Process Engineering at University of British Columbia. Dr. Brimacombe has held a number of teaching, professional and research positions at the university since his first appointment there in 1970. An Officer of the Order of Canada and a recipient of the NSERC 1997 Canada Gold Medal for Science and Engineering, Dr. Brimacombe is a member of several professional associations including The Metallurgical Society of the Canadian Institute of Mining, Metallurgy & Petroleum Engineers, and the Royal Society of Canada. Born in Windsor, Nova Scotia, Dr. Brimacombe received a B.A.Sc. Hons., from the University of British Columbia in 1966, a Ph.D. from the Imperial College (University of London) in 1970, and a D.Sc. (Eng.) from the University of London in 1986. 

Dr. Denis Gagnon 
Dr. Gagnon is former Vice-Rector Research at Université Laval where he held appointments since 1975. During his career at Laval, Dr. Gagnon also served as Vice Dean, Research and Graduate Studies at the School of Medicine, as chairman of the department of Pharmacology, and as a member of both the University Council and Board. From 1968 to 1975, Dr. Gagnon held teaching positions in the Department of Pharmacology at the Université de Sherbrooke's School of Medicine. A Member of the Order of Canada, Dr. Gagnon has also served as a member of the executive committees of several national and provincial research organizations including the Medical Research Council, the Natural Sciences and Engineering Research Council and the Fonds de la recherche en santé du Québec. In 1992, Dr. Gagnon headed a review of the drug approval system in Canada. Born in Québec City, Dr. Gagnon received a B.A. in Pharmacy from Université Laval in 1963, and, from McGill University, an M.Sc. in Pharmacology in 1965 and a Ph.D. in Pharmacology in 1967. 

Dr. Jim Friesen 
Chair of the Banting and Best Department of Medical Research at the University of Toronto since 1996, Dr. Friesen is also Senior Scientist and former Director at the Research Institute of the Hospital for Sick Children in Toronto. Dr. Friesen has held teaching and research positions at the University of Copenhagen, York University and Kansas State University. Since 1981, he has held teaching and administrative positions with the departments of Medical Genetics and Medical Biophysics at the University of Toronto. A Fellow of the Royal Society of Canada, Dr. Friesen also serves on several boards and advisory committees, including the board of directors of the Eye Research Institute of Canada, the Ontario Council on Biotechnology and the National Biotechnology Advisory Committee. Born in Rosthern, Saskatchewan, Dr. Friesen received a B.A. (Physics) from the University of Saskatchewan in 1956, an M.A. (Physics) from the University of Saskatchewan in 1958, and a Ph.D. (Medical Biophysics) from the University of Toronto in 1962. 

Dr. Art Hanson 
Dr. Hanson is President and Chief Executive Officer of the International Institute for Sustainable Development. From 1978 to 1991, he was Professor of Environmental Studies at Dalhousie University and for a decade was Director of the School for Resources and Environment Studies. Prior to that, he worked for five years with the Ford Foundation in Indonesia. He is a member of the China Council for International Cooperation on Environment and Development, an advisor to the Volvo Environment Prize, and serves on numerous Canadian and international environment and development committees. Dr. Hanson is currently a member of Canada's National Round Table on the Environment and the Economy. 

Dr. Monique Lefebvre 
Dr. Lefebvre has been President of Quebecor Multimedia since 1996. From 1991 to 1996, she was President and Chief Executive Officer of the Computer Research Institute of Montreal. Previously, she held the positions of Academic Vice Principal (1986-91) and Dean of Graduate Studies and Research (1983-86) at the Université du Québec à Montréal. Dr. Lefebvre is currently President of the board of directors of Société Innovatech du Grand Montréal as well as a member of several boards including the Conseil du réseau technologique de Montréal, the Centre de promotion du logiciel québécois and, until recently, the National Advisory Board on Science and Technology. 

Dr. Julia Levy 
Dr. Levy is President, Chief Executive Officer and Chief Scientific Officer at QLT PhotoTherapeutics Inc. in Vancouver. She is also a professor of Microbiology in the Faculty of Science at the University of British Columbia. Dr. Levy is a Fellow of the Royal Society of Canada and Past President of both the Canadian Federation of Biological Sciences and the Canadian Society of Immunologists. Dr. Levy served as a member of the National Advisory Board on Science and Technology from 1987 to 1990, on the British Columbia Science Council in 1988 and is currently a member of the NSERC Council. She has received several awards including a Gold Medal from the Science Council of British Columbia (1982), the Killam Senior Research Award (1986) and the Woman of Distinction Award for outstanding contributions to health and education (1989). 

Mrs. Judith Maxwell 
President and founder of the Canadian Policy Research Networks, Mrs. Maxwell is a highly regarded commentator and analyst of economic and social issues in Canada. Mrs. Maxwell was Chair of the Economic Council of Canada from 1985 to 1992. Prior to 1985, she worked as a consultant, as Director of Policy Studies at the C.D. Howe Institute and as a journalist. Mrs. Maxwell is an adjunct Professor at the University of Ottawa and a Fellow of the School of Policy Studies at Queen's University. She is a Member of the Order of Canada and has received honorary degrees from six Canadian universities. She holds a B.Com. from Dalhousie (1963). 

Mrs. Edythe A. Parkinson-Marcoux 
Mrs. Parkinson-Marcoux is the former President of CS Resources Limited, which was amalgamated into PanCanadian Petroleum in September 1997. Prior to joining CS Resources in 1996, Mrs. Parkinson-Marcoux was, for five years, Executive Vice President of Suncor Inc., Oil Sands Group. Previously, she held several senior executive positions with Ontario Hydro, Imperial Oil and Petro-Canada. Mrs. Parkinson-Marcoux serves on several prominent associations and committees including the Alberta Chamber of Resources, the Alberta Economic Development Authority, and the National Round Table on the Environment and the Economy. Born in Dartmouth, Nova Scotia, Mrs. Parkinson-Marcoux is a graduate of Queen's University; she earned a B.A. Sc. in Mineral Processing & Metallurgy in 1970, an Honours MBA in 1976, and an honorary D.Sc. degree in 1997. 

Mr. Guy Saint-Pierre 
Mr. Saint-Pierre was appointed Chairman of the Board of the SNC-Lavalin Group Inc. in May 1996. From January 1989 until his appointment as Chairman of the Board, Mr. Saint-Pierre was President and Chief Executive Officer of SNC-Lavalin Group Inc. During his distinguished career, Mr. Saint-Pierre served as Minister of Education and later as Minister of Industry and Commerce in the Québec Government (1972-76), as a senior executive with John Labatt and as Chief Executive Officer with Ogilvie Mills from 1978-88. An Officer of the Order of Canada, Mr. Saint-Pierre is also a member of several prominent corporate boards including The Royal Bank of Canada, BCE, Alcan, and GM of Canada. Born in Windsor Mills, Québec, Mr. Saint-Pierre received a B.Sc. from Université Laval in 1957, a D.I.C. from the Imperial College of Science and Technology in 1958 and a M.Sc. from the University of London in 1959. 

Dr. Matt Spence 
Dr. Spence has been President and Chief Executive Officer of the Alberta Heritage Foundation for Medical Research since 1990. Earlier in his career, he was Chief of Research at the Izaak Walton Killam Hospital for Children in Halifax and Associate Professor of Pediatrics and Assistant Professor of Biochemistry at Dalhousie University. Dr. Spence serves on many councils and boards including the Health Services Research Foundation, the Neurosciences Partners Fund and the Health Research Industry Task Force Ministerial Committee. Among his awards is a Distinguished Service Award from the Canadian Society for Clinical Investigation. Dr. Spence received his M.D. from the University of Alberta in 1959 and a Ph.D. from McGill University in 1966. 

Dr. Ron Steer 
Dr. Steer is a Thorvaldson Professor of Chemistry at the University of Saskatchewan, where he has held several teaching, research and administrative posititons since 1969. An accomplished researcher, Dr. Steer has held research grants from the Natural Sciences and Engineering Research Council, the Centre of Excellence in Molecular and Interfacial Dynamics, and the North Atlantic Treaty Organization. He has been a member of several professional and scientific organizations, including the Natural Sciences and Engineering Research Council of Canada, and has served as President of the Canadian Society for Chemistry. Dr. Steer is a graduate of the University of Saskatchewan where he received a B.A. in 1963, a Ph.D. in 1968 and a D.Sc. in 1995. 

FIRST SIX MEMBERS APPOINTED TO THE CANADA FOUNDATION FOR INNOVATION
 

Dr. Martha Piper President and Vice-Chancellor, University of British Columbia
Dr. Peter J. Nicholson Executive Vice-President, Corporate Strategy, BCE Inc.
Dr. Angus Bruneau Chairman of the Board, Fortis Inc.; Chairman, Air Nova
Dr. Gilles Cloutier Consultant; former Rector, Université de Montréal
Ms. Dorothy Lamont Chief Executive Officer, Canadian Cancer Society and National Cancer Institute of Canada
Mr. Robert J. Giroux President, Association of Universities and Colleges of Canada